Skip to main content
Log in

Impact of the learning curve on outcome after transcatheter mitral valve repair: results from the German Mitral Valve Registry

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Aims

This analysis from the German Mitral Valve Registry investigates the impact of the learning curve with the MitraClip® technique on procedural success and complications.

Methods and results

Consecutive patients treated since 2009 in centers that performed more than 50 transcatheter mitral repairs were included. Results of the first half of the patients were compared to those of the second. Altogether 496 patients from 10 centers were included. Patients treated later had less common severe heart failure symptoms (patients with NYHA IV: 22.1 vs. 14.5 %, p < 0.05). The EuroSCORE I (22.0 vs. 23.0 %, p = ns) and Society of Thoracic Surgeons (STS) score (7.5 vs. 9.5 %, p = ns) did not differ between both groups. Procedural success was 95.6 % (238/249) in the first cases and 94.7 % (232/245, p = ns) subsequently. Also procedural time (104.3 vs. 119 min, p = ns) and complications did not decrease over time.

Conclusion

A learning curve using the MitraClip® device does not appear to significantly affect acute MR reduction, hospital and 30-day mortality. Most likely, the proctor system leads to already high initial procedure success and relatively short procedure time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395–1406

    Article  PubMed  CAS  Google Scholar 

  2. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 54:686–694

    Article  PubMed  Google Scholar 

  3. Schillinger W, Athanasiou T, Weicken N, Berg L, Tichelbacker T, Puls M, Hunlich M, Wachter R, Helms HJ, Seipelt R, Schondube FA, Hasenfuss G (2011) Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip(R) and lessons learned after the first 75 consecutive patients. Eur J Heart Fail 13:1331–1339

    Article  PubMed  Google Scholar 

  4. Baldus S, Schillinger W, Franzen O, Bekeredjian R, Sievert H, Schofer J, Kuck KH, Konorza T, Mollmann H, Hehrlein C, Ouarrak T, Senges J, Meinertz T (2012) MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail 14:1050–1055

    Article  PubMed  Google Scholar 

  5. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, Treede H, Barmeyer A, Schofer J, Costard-Jackle A, Schluter M, Reichenspurner H, Meinertz T (2010) Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 31:1373–1381

    Article  PubMed  Google Scholar 

  6. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16:777–802

    Article  PubMed  Google Scholar 

  7. Roques F, Nashef SA, Michel P (2001) Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis 10:572–577 (discussion 577–8)

    PubMed  CAS  Google Scholar 

  8. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, St Goar F, Rodriguez L, Silvestry F, Schwartz A, Sanborn TA, Condado JA, Foster E (2005) Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 46:2134–2140

    Article  PubMed  Google Scholar 

  9. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, La Canna G (2001) The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 122:674–681

    Article  PubMed  CAS  Google Scholar 

  10. Gaemperli O, Moccetti M, Surder D, Biaggi P, Hurlimann D, Kretschmar O, Buehler I, Bettex D, Felix C, Luscher TF, Falk V, Grunenfelder J, Corti R (2011) Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes. Heart 98:126–132

    Article  PubMed  Google Scholar 

  11. Ihlemann N, Franzen O, Jorgensen E, Hansen PB, Hassager C, Moller JE, Sondergaard L (2011) Promising results after percutaneous mitral valve repair. Dan Med Bull 58:A4299

    PubMed  Google Scholar 

  12. Pleger ST, Mereles D, Schulz-Schonhagen M, Krumsdorf U, Chorianopoulos E, Rottbauer W, Katus HA, Bekeredjian R (2011) Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients. Am J Cardiol 108:1478–1482

    Article  PubMed  Google Scholar 

  13. Tamburino C, Ussia GP, Maisano F, Capodanno D, La Canna G, Scandura S, Colombo A, Giacomini A, Michev I, Mangiafico S, Cammalleri V, Barbanti M, Alfieri O (2010) Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 31:1382–1389

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Van den Branden BJ, Post MC, Swaans MJ, Rensing BJ, Eefting FD, Plokker HW, Jaarsma W, Van der Heyden JA (2010) Percutaneous mitral valve repair using the edge-to-edge technique in a high-risk population. Neth Heart J 18:437–443

    Article  PubMed  PubMed Central  Google Scholar 

  15. Franzen O (2011) What have we learned from the EU experience. TCT

  16. Paranskaya L, Turan I, Kische S, Nienaber C, Ince H (2011) Rapid pacing facilitates grasping and MitraClip implantation in severe mitral leaflet prolapse. Clin Res Cardiol 101:69–71

    Article  PubMed  Google Scholar 

  17. Mayr NP, Martin K, Hausleiter J, Brown A, Tassani P (2011) Ventilation manoeuvres facilitate MitraClip placement. Heart 97:1717 (author reply 1717)

    Article  PubMed  Google Scholar 

  18. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496

    Article  PubMed  Google Scholar 

  19. Braun D, Lesevic H, Orban M, Michalk F, Barthel P, Hoppe K, Sonne C, Pache J, Mehilli J, Kastrati A, Hausleiter J, Massberg S (2013) Percutaneous edge-to-edge repair of the mitral valve in patients with degenerative versus functional mitral regurgitation. Catheter Cardiovasc Interv. doi:10.1002/ccd.25331

    PubMed  Google Scholar 

  20. Rudolph V, Knap M, Franzen O, Schluter M, de Vries T, Conradi L, Schirmer J, Treede H, Wegscheider K, Costard-Jackle A, Meinertz T, Reichenspurner H, Baldus S (2011) Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol 58:2190–2195

    Article  PubMed  Google Scholar 

  21. Grasso C, Capodanno D, Scandura S, Cannata S, Imme S, Mangiafico S, Pistritto A, Ministeri M, Barbanti M, Caggegi A, Chiaranda M, Dipasqua F, Giaquinta S, Occhipinti M, Ussia G, Tamburino C (2013) One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). Am J Cardiol 111:1482–1487

    Article  PubMed  Google Scholar 

  22. Boekstegers P, Hausleiter J, Baldus S, von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schafer U, Schillinger W, Wunderlich N (2014) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103:85–96

    Article  PubMed  CAS  Google Scholar 

  23. Corti R (2012) Real-word european experience with transcatheter treatment of significant mitral regurgitation: demographies and procedural outcomes. PCR London Valves

  24. Paranskaya L, Kische S, Bozdag-Turan I, Nienaber C, Ince H (2012) Mitral valve with three orifices after percutaneous repair with the MitraClip system: the triple-orifice technique. Clin Res Cardiol 101:847–849

    Article  PubMed  CAS  Google Scholar 

  25. Auricchio A, Schillinger W, Meyer S, Maisano F, Hoffmann R, Ussia GP, Pedrazzini GB, van der Heyden J, Fratini S, Klersy C, Komtebedde J, Franzen O (2011) Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 58:2183–2189

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Jakob Ledwoch: None.

Jennifer Franke: None.

Stephan Baldus: Research Grants and lecture fees from Abbott Vascular.

Wolfgang Schillinger: Advisory board, consulting fees, lectures fees and reimbursement for travel expenses from Abbott Vascular.

Raffi Bekeredjian: None.

Peter Boekstegers: None.

Ulrich Hink: Reimbursement for travel expenses from Abbott Vascular.

Karl-Heinz Kuck: None.

Taoufik Ouarrak: None.

Helge Möllmann: Speakers honoraria Abbott Vascular and Edwards Lifesciences.

Georg Nickenig: None.

Jochen Senges: None.

Olaf Franzen: Proctoring and speakers’ office and research grant Abbott Vascular.

Horst Sievert: Study honorary, travel expenses, consulting fees from Access Closure, AGA, Angiomed, Ardian, Arstasis, Atritech, Atrium, Avinger, Bard, Boston Scientific, Bridgepoint, CardioKinetix, CardioMEMS, Coherex, Contego, CSI, EndoCross, EndoTex, Epitek, Evalve, ev3, FlowCardia, Gore, Guidant, Lumen Biomedical, HLT, Kensey Nash, Kyoto Medical, Lifetech, Lutonix, Medinol, Medtronic, NDC, NMT, OAS, Occlutech, Osprey, Ovalis, Pathway, PendraCare, Percardia, pfm Medical, Recor, Rox Medical, Sadra, Sorin, Spectranetics, SquareOne, Trireme, Trivascular, Viacor, Velocimed, Veryan.

Stock options from Cardiokinetix, Access Closure, Velocimed, CoAptus, Lumen Biomedical, Coherex.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Horst Sievert.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ledwoch, J., Franke, J., Baldus, S. et al. Impact of the learning curve on outcome after transcatheter mitral valve repair: results from the German Mitral Valve Registry. Clin Res Cardiol 103, 930–937 (2014). https://doi.org/10.1007/s00392-014-0734-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-014-0734-y

Keywords

Navigation